@article{95b328fb3d7d4c7b922399e0a4f45fa1,
title = "Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors",
keywords = "Prospective Studies, Immune Checkpoint Inhibitors/therapeutic use, Humans, Middle Aged, Ipilimumab/therapeutic use, Male, Nivolumab/therapeutic use, Desmoid Tumors/drug therapy, Young Adult, Adolescent, Female, Adult, Aged, CTLA-4 Antigen/antagonists \& inhibitors, Programmed Cell Death 1 Receptor/antagonists \& inhibitors",
author = "Chae, \{Young Kwang\} and Megan Othus and Sandip Patel and Benjamin Powers and Hsueh, \{Chung Tsen\} and Rangaswamy Govindarajan and Silvana Bucur and Kim, \{Hye Sung\} and Chung, \{Liam IL Young\} and Christine McLeod and Chen, \{Helen X.\} and Elad Sharon and Howard Streicher and Ryan, \{Christopher W.\} and Charles Blanke and Razelle Kurzrock",
note = "{\textcopyright} Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2024",
month = sep,
day = "28",
doi = "10.1136/jitc-2024-009128",
language = "English",
volume = "12",
journal = "Journal for immunotherapy of cancer",
issn = "2051-1426",
number = "9",
}